Silverman Gregg J., Sasano Minoru, Wormsley Susan B.
{"title":"The Variable-Region Specificity of Bacterial Fab-Binding Proteins: The Search for B-Cell Superantigens","authors":"Silverman Gregg J., Sasano Minoru, Wormsley Susan B.","doi":"10.1006/immu.1993.1004","DOIUrl":null,"url":null,"abstract":"<div><p>Due to the biologic implications for clinical infection, defining the Fab-binding specificities of certain bacterial Ig-binding proteins has been an area of considerable interest. To elucidate the structural and genetic correlates of the Fab-binding specificity of a prototypic Fab-binding bacterial protein, staphylococcal protein A (SpA), we have developed several new approaches. In earlier studies, we used a panel of peptide-induced serologic reagents to identify the V-region family usage in monoclonal Ig and then assessed their binding interaction with the Fab-specific binding site of SpA. To identify the conserved V-region sequences that correlate with SpA binding, the SpA-binding abilities of a group of purified, B-cell-line derived, monoclonal Ig of known sequence were also assessed. More recently, we have studied the binding of SpA with a combinatorial Ig expression library made with a phage surface-display vector. These studies have rigorously demonstrated that SpA binding is restricted to V<sub>H</sub>3 Fab: The vast majority of V<sub>H</sub>3 Fab bind SpA, and diverse V<sub>H</sub>3 genes can encode for SpA binding. We then used the labeled Fab-specific SpA as a V<sub>H</sub>3-specific phenotypic marker in multiparameter flow cytometric analyses to study human B-cell repertoire expression. These studies indicate that SpA possesses the Fab-binding specificity predicted for a B-cell superantigen, and we speculate that this type of unconventional antigen may have potent capabilities of influencing the formation of human immune repertoires.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"2 1","pages":"Pages 17-32"},"PeriodicalIF":0.0000,"publicationDate":"1993-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1004","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ImmunoMethods","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1058668783710041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
Abstract
Due to the biologic implications for clinical infection, defining the Fab-binding specificities of certain bacterial Ig-binding proteins has been an area of considerable interest. To elucidate the structural and genetic correlates of the Fab-binding specificity of a prototypic Fab-binding bacterial protein, staphylococcal protein A (SpA), we have developed several new approaches. In earlier studies, we used a panel of peptide-induced serologic reagents to identify the V-region family usage in monoclonal Ig and then assessed their binding interaction with the Fab-specific binding site of SpA. To identify the conserved V-region sequences that correlate with SpA binding, the SpA-binding abilities of a group of purified, B-cell-line derived, monoclonal Ig of known sequence were also assessed. More recently, we have studied the binding of SpA with a combinatorial Ig expression library made with a phage surface-display vector. These studies have rigorously demonstrated that SpA binding is restricted to VH3 Fab: The vast majority of VH3 Fab bind SpA, and diverse VH3 genes can encode for SpA binding. We then used the labeled Fab-specific SpA as a VH3-specific phenotypic marker in multiparameter flow cytometric analyses to study human B-cell repertoire expression. These studies indicate that SpA possesses the Fab-binding specificity predicted for a B-cell superantigen, and we speculate that this type of unconventional antigen may have potent capabilities of influencing the formation of human immune repertoires.